National and Kapodistrian University of Athens
Ο ρόλος του Cdc6 σε παρατεταμένη p21 waf1/cip1 επαγώμενη αναστολή: ο ρόλος του μονοπατιού στην καρκινογένεση
Abstract
dc:descriptionThe cyclin-dependent kinase inhibitor p21WAF1/Cip1 (p21) is a cell-cycle checkpoint effector and inducer of senescence, regulated by p53. Yet, evidence suggests that, through a so-far obscure mechanism, p21 could also be oncogenic. We report that a subset of atypical cancerous-cells strongly expressing p21 showed proliferation features. This occurred predominantly in p53-mutant human-cancers suggesting p53-independent upregulation of p21 selectively in more aggressive tumour cells. Multifaceted phenotypic and genomic analyses of p21-inducible, p53-null, cancerous and near-normal cellular models showed that after an initial senescence-like phase, a subpopulation of p21-expressing proliferating cells emerged, featuring increased genomic instability, aggressiveness and chemo-resistance. Mechanistically, sustained p21-accumulation inhibited CRL4CDT2 and SCFSkp2 ubiquitin-ligases, leading to deregulated origin licensing and replication stress. Collectively, our data shed reveal tumour-promoting ability of p21 through deregulation of DNA replication licensing machinery, an unorthodox role to be considered in cancer treatment, since p21 responds to various stimuli including some chemotherapy drugs.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2015
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Galanos, Panagiotis
- Γαλανός, Παναγιώτης
Subjects
dc:subject × 5Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/36755